Advertisement

Research Article Free access | 10.1172/JCI117514

Tamoxifen blocks chloride channels. A possible mechanism for cataract formation.

J J Zhang, T J Jacob, M A Valverde, S P Hardy, G M Mintenig, F V Sepúlveda, D R Gill, S C Hyde, A E Trezise, and C F Higgins

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Zhang, J. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Jacob, T. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Valverde, M. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Hardy, S. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Mintenig, G. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Sepúlveda, F. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Gill, D. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Hyde, S. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Trezise, A. in: JCI | PubMed | Google Scholar

Department of Physiology, University of Wales, Cardiff, United Kingdom.

Find articles by Higgins, C. in: JCI | PubMed | Google Scholar

Published October 1, 1994 - More info

Published in Volume 94, Issue 4 on October 1, 1994
J Clin Invest. 1994;94(4):1690–1697. https://doi.org/10.1172/JCI117514.
© 1994 The American Society for Clinical Investigation
Published October 1, 1994 - Version history
View PDF
Abstract

Tamoxifen is an antiestrogen frequently used in the treatment of breast cancer and is currently being assessed as a prophylactic for those at high risk of developing tumors. We have found that tamoxifen and its derivatives are high-affinity blockers of specific chloride channels. This blockade appears to be independent of the interaction of tamoxifen with the estrogen receptor and therefore reflects an alternative cellular target. One of the clinical side effects of tamoxifen is impaired vision and cataract. Chloride channels in the lens of the eye were shown to be essential for maintaining normal lens hydration and transmittance. These channels were blocked by tamoxifen and, in organ culture, tamoxifen led to lens opacity associated with cataracts at clinically relevant concentrations. These data suggest a molecular mechanism by which tamoxifen can cause cataract formation and have implications for the clinical use of tamoxifen and related antiestrogens.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (October 1, 1994): No description
Advertisement
Advertisement